Pyridoxal 5'-Phosphate not checked

Medicure

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
3 active
3 in total · 1 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency (2 trials)
Main trialPhase 3
“The proposed clinical study is intended to evaluate oral P5P for the treatment of patients confirmed to have Pyridox(am)ine 5'-Phosphate Oxidase (PNPO) deficiency via genetic analysis. There is an unmet clinical need for pharmaceutical grade P5P, as to date none has been made commercially available. Patients will receive pharmaceutical grade P5P according to their normal oral P5P dosing regimen, as previously established by their physicians.”In the company’s words, NCT04706013 on ClinicalTrials.gov
Other names
Pyridoxal Phosphate

Coming up2

Changes1

Last 90 days

Trials3

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Sep 2027 Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Phase 3Recruiting 15 Jul 2029 Continuation Study With Oral MC-1 for Treatment of Patients With PNPO-Deficiency
Phase 3Authorised not given Study of Oral MC-1 for the Treatment of Patients with PNPO Deficiency
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Pyridoxal 5'-Phosphate

Following is part of Solo: you see every change to Pyridoxal 5'-Phosphate the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in